本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trinity Biotech plc

10.59
-0.0100-0.09%
成交量:6,111
成交額:6.30萬
市值:861.07萬
市盈率:-0.18
高:10.59
開:10.25
低:10.22
收:10.60
52周最高:52.50
52周最低:7.94
股本:81.31萬
流通股本:66.91萬
量比:0.15
換手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-60.3628
每股收益(LYR):-60.3628
淨資產收益率:-1913.45%
總資產收益率:-5.72%
市淨率:-0.12
市盈率(LYR):-0.18

資料載入中...

2026/08/21

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/06/03

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/20

SEC問詢函

Form CORRESP - Correspondence
2026/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/02/28

SEC問詢函

Form CORRESP - Correspondence
2026/02/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2026/01/22

SEC問詢函

Form CORRESP - Correspondence
2026/01/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/05/16

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/11/29

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/05/03

SEC問詢函

Form CORRESP - Correspondence
2024/05/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]